Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Latest From Cardinal Health, Inc.

Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024

Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.

Clinical Trials Drug Approval Standards

OKYO Hits Multiple Dry Eye Endpoints, Plans Move Into Phase III

OKYO’s eye drop OK-101 has hit endpoints for ocular pain, tear film breakup time and conjunctival staining in Phase II, while demonstrating a placebo-like tolerability profile.

Clinical Trials Drug Approval Standards

Andera Reflects On Revitalized Biotech Scene

After AstraZeneca’s acquisition of Amolyt made the Paris-based investment group a tidy profit, Andera spoke to Scrip about the rejuvenated investment market in Europe.

M & A Business Strategies

News We’re Watching: First OTC Blood Glucose Monitor, Recalls For Ventec and Medtronic, Guidance Docs Under White House Review

This week, the US FDA announced that it had cleared Dexcom’s Stelo Glucose Biosensor System, making it the first OTC device of its type available in the US. Additionally, the Office of Management and Budget took up guidance documents on cybersecurity and enforcement on diagnostics during emergencies, and recalls were announced by Medtronic, Ventec and Cardinal.

FDA Regulation
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Distributors
  • Medical Devices
  • Services
  • Services
    • Home Infusion
    • Hospitals, Nursing Homes, Institutions
    • Pharmacy Services, PBMs
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
  • Other Names / Subsidiaries
    • AccessClosure
    • Allegiance Healthcare Corporation
    • Cordis Corporation
    • Innovative Therapies, naviHealth
    • OutcomesMTM
    • The Harvard Drug Group
    • VIASYS Healthcare